Scholarlink

Background <p>Alport syndrome is a rare genetic disorder characterized by progressive renal impairment, hearing loss, and ocular abnormalities. Our study aimed to elucidate global research trends on Alport syndrome through bibliometric analysis.</p> Methods <p>A comprehensive bibliometric analysis of Alport syndrome literature (1990–2025) was performed using WoS and Scopus. After merging and de-duplication (n = 2371), CiteSpace, VOSviewer, and Bibliometrix facilitated network visualization, co-occurrence, co-citation, and historiographic evaluations.</p> Results <p>Research on Alport syndrome has grown exponentially since 1990 (2371 documents; 6.04% annual growth), dominated by original articles and moderate international collaboration. The USA leads in output, collaboration, and citations; China’s volume is rising with evolving global impact. A hub-and-cluster author structure (e.g., Savige, Gross, Kashtan) publishes mainly in nephrology journals (Kidney International, JASN, Pediatric Nephrology), with interdisciplinary citation flows. Co-citation and bursts trace a shift from GBM/type IV collagen genetics to precision diagnostics and renoprotective therapy. Landmark studies established COL4 mutations, genotype–phenotype links, and early ACE inhibition, defining a gene–structure–phenotype–therapy axis.</p> Conclusion <p>Alport syndrome research has progressed from genetic discovery toward more integrative and precision-focused approaches, supported by expanding global collaboration and contributions from key nephrology journals. Emerging priorities—including earlier diagnosis, renoprotective strategies, and advanced molecular techniques—reflect a sustained shift toward more personalized research directions that may inform future clinical management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Bibliometric analysis of Alport syndrome: genetic foundations, clinical implications, and the transition to precision medicine

  • 期刊论文

  • 发表日期：

    2026年3月28日

查看全文
  • Hui Tian,
  • Minheng Zhang

摘要

Background

Alport syndrome is a rare genetic disorder characterized by progressive renal impairment, hearing loss, and ocular abnormalities. Our study aimed to elucidate global research trends on Alport syndrome through bibliometric analysis.

Methods

A comprehensive bibliometric analysis of Alport syndrome literature (1990–2025) was performed using WoS and Scopus. After merging and de-duplication (n = 2371), CiteSpace, VOSviewer, and Bibliometrix facilitated network visualization, co-occurrence, co-citation, and historiographic evaluations.

Results

Research on Alport syndrome has grown exponentially since 1990 (2371 documents; 6.04% annual growth), dominated by original articles and moderate international collaboration. The USA leads in output, collaboration, and citations; China’s volume is rising with evolving global impact. A hub-and-cluster author structure (e.g., Savige, Gross, Kashtan) publishes mainly in nephrology journals (Kidney International, JASN, Pediatric Nephrology), with interdisciplinary citation flows. Co-citation and bursts trace a shift from GBM/type IV collagen genetics to precision diagnostics and renoprotective therapy. Landmark studies established COL4 mutations, genotype–phenotype links, and early ACE inhibition, defining a gene–structure–phenotype–therapy axis.

Conclusion

Alport syndrome research has progressed from genetic discovery toward more integrative and precision-focused approaches, supported by expanding global collaboration and contributions from key nephrology journals. Emerging priorities—including earlier diagnosis, renoprotective strategies, and advanced molecular techniques—reflect a sustained shift toward more personalized research directions that may inform future clinical management.